Clinical Trials in Houston

Showing 6421-6440 of 17,885 trials

Study to Assess the Safety of Escalating Doses of AT9283, in Patients With Leukemias

NCT00522990

The goal of this clinical research study is to find the highest tolerable dose of AT9283 that can be given to patients who have ALL, AML, CML, high-risk myelodysplastic syndromes, or myelofibrosis with myeloid metaplasia. Researchers want to perform pharmacokinetic (PK) testing on blood to find out how quickly the study drug leaves the body and how the body breaks down the drug. The safety and effectiveness of this drug will also be studied.

Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaChronic Myeloid Leukemia+2 more

Astex Pharmaceuticals, Inc.48 participantsStarted Sep 2006

Birmingham, Alabama, United States • Houston, Texas, United States

TERMINATEDPhase 3< 1 mile

A Randomized Trial of Low-Dose Bevacizumab vs Laser for Type 1 ROP

NCT04634604

This randomized clinical trial will compare retinal outcomes with low-dose intravitreous bevacizumab (0.063 mg) versus laser photocoagulation as treatment for infants with type 1 retinopathy of prematurity (ROP). The study also will assess neurodevelopment, refractive error, visual acuity, and peripheral visual fields.

Retinopathy of Prematurity

Jaeb Center for Health Research16 participantsStarted Apr 2022

Phoenix, Arizona, United States • Little Rock, Arkansas, United States • Irvine, California, United States +32 more locations

Study to Assess the Safety of Escalating Doses of AT9283, in Patients With Leukemias

A Randomized Trial of Low-Dose Bevacizumab vs Laser for Type 1 ROP

Find Trials by Condition in Houston

A Study to Assess the Safety, Pharmacokinetics, and Antitumor Activity of Oral TACH101 in Participants With Advanced or Metastatic Cancer

ILUMIEN IV: OPTIMAL Percutaneous Coronary Intervention (PCI)

Efficacy and Safety of Roxadustat for Treatment of Anemia in Participants With Lower Risk Myelodysplastic Syndrome With Low Red Blood Cell Transfusion Burden

Tagraxofusp in Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm or Acute Myeloid Leukemia

Study to Evaluate the Efficacy and Safety of Once-Weekly Oral NBI-1065846 in the Treatment of Anhedonia in MDD

Investigation of Genetic Determinants of Capecitabine Toxicity

Tagraxofusp in Treating Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm After Stem Cell Transplant

A Dose Escalation Study Evaluating the Safety and Tolerability of GDC-0032 in Participants With Locally Advanced or Metastatic Solid Tumors or Non-Hodgkin's Lymphoma (NHL) and in Combination With Endocrine Therapy in Locally Advanced or Metastatic Hormone Receptor-Positive Breast Cancer

A Study to Evaluate the Effectiveness and Safety of SKI-O-703 in Patients Experiencing Active Rheumatoid Arthritis Despite Treatment With Conventional Therapies.

Zibotentan and Dapagliflozin for the Treatment of CKD (ZENITH-CKD Trial)

Trial to Learn About the Study Medicine (PF-07081532) and Rybelsus in People With Type 2 Diabetes and Separately PF-07081532 in People With Obesity

Phase 1b Study to Assess Safety, Tolerability, and Pharmacokinetics of ARCT-810 in Stable Adult Subjects With Ornithine Transcarbamylase Deficiency

Effect of AEF0117 on Treatment-seeking Patients With Cannabis Use Disorder (CUD)

The clonoSEQ® Watch Registry

Gut and Tumor Microbiome in Patients With Early Stage (II-III), Locally Advanced or Advanced ER-positive and HER2-negative Breast Cancer.

Continued Access to the Recell® Device for Treatment of Acute Burn Injuries

Seeded Cells on Matrix Plug Treating Crohn's Perianal Fistulas (STOMP-II)

A Study of Ramucirumab Plus Pembrolizumab in Participants With Gastric or GEJ Adenocarcinoma, NSCLC, Transitional Cell Carcinoma of the Urothelium, or Biliary Tract Cancer